Work

Faculty Opinions recommendation of Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma.

Year: 2011

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.8357958.8804055

Author: Robert Kreitman

Institutions: National Institutes of Health, National Cancer Institute

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4254658074

Cites:

Cited by: 1

Related to: 10